LGALS3 and Parkinson disease: The potential involvement of Gal-3 in the pathology associated with aged-related, familial and acute neurodegenerative diseases is exemplified by increased serum or CSF levels of this lectin in AD, PD, ALS, TBI, and stroke, thus increasing its utility as a potential biomarker in disease progression.